0001140361-23-058049.txt : 20231218 0001140361-23-058049.hdr.sgml : 20231218 20231218092311 ACCESSION NUMBER: 0001140361-23-058049 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230711 FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KNIGHT THERAPEUTICS INTERNATIONAL SA CENTRAL INDEX KEY: 0001632373 ORGANIZATION NAME: STATE OF INCORPORATION: X3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41719 FILM NUMBER: 231492426 BUSINESS ADDRESS: STREET 1: DR LUIS BONAVITA 1294 STREET 2: OFFICE 2004 CITY: MONTEVIDEO STATE: X3 ZIP: 11300 BUSINESS PHONE: 982-626-2344 MAIL ADDRESS: STREET 1: DR LUIS BONAVITA 1294 STREET 2: OFFICE 2004 CITY: MONTEVIDEO STATE: X3 ZIP: 11300 FORMER NAME: FORMER CONFORMED NAME: Knight Therapeutics (Barbados) Inc. DATE OF NAME CHANGE: 20150130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knight Therapeutics Inc CENTRAL INDEX KEY: 0001756235 ORGANIZATION NAME: STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41719 FILM NUMBER: 231492427 BUSINESS ADDRESS: STREET 1: 3400 BOULEVARD DE MAISONNEUVE WEST STREET 2: SUITE 1055 CITY: MONTREAL STATE: A8 ZIP: H3Z 3B8 BUSINESS PHONE: 5144844483 MAIL ADDRESS: STREET 1: 3400 BOULEVARD DE MAISONNEUVE WEST STREET 2: SUITE 1055 CITY: MONTREAL STATE: A8 ZIP: H3Z 3B8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 60 DEGREES PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001946563 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 452406880 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1025 CONNECTICUT AVENUE NW STREET 2: SUITE 1000 CITY: WASHINGTON STATE: DC ZIP: 20036 BUSINESS PHONE: 202-327-5422 MAIL ADDRESS: STREET 1: 1025 CONNECTICUT AVENUE NW STREET 2: SUITE 1000 CITY: WASHINGTON STATE: DC ZIP: 20036 3 1 form3.xml X0206 3 2023-07-11 0 0001946563 60 DEGREES PHARMACEUTICALS, INC. SXTP 0001756235 Knight Therapeutics Inc 3400 DE MAISONNEUVE W. SUITE 1055 MONTREAL A8 H3Z 3B8 QUEBEC, CANADA true 0001632373 KNIGHT THERAPEUTICS INTERNATIONAL SA DR. LUIS BONAVITA 1294, OF. 2004 MONTEVIDEO X3 11300 URUGUAY true Common Stock, $0.0001 par value per share ("Common Shares") 1108337 I By Knight Therapeutics International SA In addition to Knight Therapeutics Inc., a Canadian corporation ("Knight Parent"), this Form 3 is being jointly filed by Knight Therapeutics International S.A., an Uruguayan corporation ("Knight Subsidiary" and collectively with Knight Parent, the "Reporting Persons"). Knight Subsidiary directly beneficially owns 1,108,337 Common Shares. Knight Parent is the sole owner of Knight Subsidiary and, as a result, may be deemed the beneficial owner for purposes of Securities Exchange Act of 1934 (the "Act") of any securities of 60 Degrees Pharmaceuticals, Inc. (the "Issuer") beneficially owned by Knight Subsidiary. Knight Parent disclaims beneficial ownership over all of the Common Shares beneficially owned by Knight Subsidiary, other than for the purpose of determining obligations under the Act, and the filing of this Form 3 shall not be deemed an admission that Knight Parent is the beneficial owner of such securities for any other purpose. Exhibit 99.1 (Joint Filer Information) incorporated herein by reference. KNIGHT THERAPEUTICS INTERNATIONAL S.A. By: /s/ Arvind Utchanah Name: Arvind Utchanah Title: President of the Board of Directors 2023-12-14 KNIGHT THERAPEUTICS INC. By: /s/ Samira Sakhia Name: Samira Sakhia Title: President and Chief Executive Officer 2023-12-14 EX-99.1 2 ef20016451_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1

 
Joint Filer Information
 
Name of Joint Filer:
Knight Therapeutics Inc.
   
Address of Joint Filer:
3400 de Maisonneuve W. Suite 1055, Montréal, Quebec H3Z 3B8
   
Relationship of Joint Filer to Issuer:
10% Beneficial Owner
   
Issuer Name and Ticker or Trading Symbol:
60 DEGREES PHARMACEUTICAL, INC. [SXTP]
   
Date of Event Requiring Statement:
July 11, 2023
   
Designated Filer:
Knight Therapeutics Inc.
   
Signature:
  

KNIGHT THERAPEUTICS INC.

By:
/s/ Samira Sakhia    
Name: Samira Sakhia
  
Title: President and Chief Executive Officer
  
   
Date: December____, 2023
  

Name of Joint Filer:
Knight Therapeutics International S.A.
   
Address of Joint Filer:
Dr. Luis Bonavita 1294, of. 2004, Montevideo, Uruguay
   
Relationship of Joint Filer to Issuer:
10% Beneficial Owner
   
Issuer Name and Ticker or Trading Symbol:
60 DEGREES PHARMACEUTICAL, INC. [SXTP]
   
Date of Event Requiring Statement:
July 11, 2023
   
Designated Filer:
Knight Therapeutics Inc.
   
Signature:
  

KNIGHT THERAPEUTICS INTERNATIONAL S.A.

By:
/s/ Arvind Utchanah  
 
Name: Arvind Utchanah
 
Title: President of the Board of Directors
 
   
Date: December____, 2023
 


2